couter

BVNKFBavarian Nordic A/S

Oct 15, 2026 — Clinical Pipeline & Commercialization Update
Chart by TradingView

The schedule

  • Thu15Oct

    Update on clinical pipeline progress and commercialization strategy for key products.

  • Thu12Nov

    Earnings release for Q3 2026, with potential guidance on future performance and pipeline progress.

  • Wed20Jan

    Potential announcement on US biodefense procurement contracts or partnerships.

  • Thu25Feb

    Earnings release for Q4 2026 and forward guidance for FY27, with potential insights into future growth.

Past

  • Fri21Aug

    Actual outcome: Bull

    Bavarian Nordic's CEO warned that global warming is increasing the spread of tick-borne encephalitis and chikungunya viruses, potentially boosting demand for the company's vaccines. The statement, made on the day after the price move, signaled heightened awareness of the company's core market opportunities. The move reflects market anticipation of increased vaccine demand due to climate-related health threats. [Market retrospective · Ultra-Short (1–5 days)] Missed anticipation: +17.6% from 2026-08-20 to 2026-08-24 (~8.2σ vs typical 1d vol). Target evaluation date 2026-08-26 (not yet reached as of 2026-08-24). Confidence 95%. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-07: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-07 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-09: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-09 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-14: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-14 observed.

    Bavarian Nordic's CEO warned that global warming is increasing the spread of tick-borne encephalitis and chikungunya viruses, potentially boosting demand for the company's vaccines. The statement, made on the day after the price move, signaled heightened awareness of the company's core market opportunities. The move reflects market anticipation of increased vaccine demand due to climate-related health threats. [Market retrospective · Ultra-Short (1–5 days)] Missed anticipation: +17.6% from 2026-08-20 to 2026-08-24 (~8.2σ vs typical 1d vol). Target evaluation date 2026-08-26 (not yet reached as of 2026-08-24). Confidence 95%. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-07: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-07 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-09: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-09 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-14: +17.6% from 2026-08-20 (~8.2σ). Target date 2026-08-26 reached; move through 2026-09-14 observed.